Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New Standard of Care in High-Risk Acute Promyelocytic Leukemia?

2.

Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care

3.

Some low-grade prostate cancers carry higher risks than biopsy suggests

4.

Measurable Residual Disease Predicts Real-World AML Relapse

5.

The lack of psychiatrists may be addressed by community workers.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot